Continuous Infusion of rhIL-15 for Adults With Advanced Cancer
NCT01572493
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
38
Enrollment
NIH
Sponsor class
Conditions
Lymphoma
Carcinoma
Interventions
BIOLOGICAL:
rh IL-15 (10 DAYS)
BIOLOGICAL:
rh IL-15 (5 DAYS)
Sponsor
National Cancer Institute (NCI)